Directed-Complement Activation as a Novel Immunotherapeutic Approach for HER2-Breast Cancer

Seguin-Devaux C, Brandus B, Plesseria JM, Iserentant G, Servais JY, Pitiot A, Kanli G, Behrmann I, Schober R, Zimmer J, Cohen JH, Dervillez X

ImmunoTargets and Therapy 2025, 14:979-995

Published Date: 5 September 2025